在日本,MYH9相关疾病的诊断延迟
Atsushi Sakamoto1,2, Toru Uchiyama3, Tadashi Kaname4
1Center for Postgraduate Education and Training, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
British journal of haematology
|April 23, 2024
概括
与MYH9相关的疾病 (MYH9-RD) 往往导致诊断延迟,患者的平均年龄在25岁时被诊断出来,尽管指示性血小板缺血出现得更早. 这凸显了日本诊断这种先天性疾病的巨大差距.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 与MYH9相关的疾病 (MYH9-RD) 呈现出先天性巨血栓缺血和颗粒细胞入.
- 它经常被误诊为慢性免疫血小板缺血,延迟了适当的治疗.
- 诊断方面的挑战有助于对MYH9-RD的识别延迟.
研究的目的:
- 调查MYH9-RD.患者确诊时的年龄和指示性血小板缺血的年龄.
- 评估日本MYH9-RD诊断延迟的程度.
- 评估先天性血小板缺血病注册表在解决诊断问题的有用性.
主要方法:
- 分析了41名被诊断为MYH9-RD的患者的数据.
- 利用了日本的先天性血栓塞缩症注册表,用于患者队列.
- 确定诊断时的中位数年龄与指示性血小板缺血的中位数年龄进行比较.
主要成果:
- 研究队列包括54.8%的确诊时18岁以上的成年人.
- 在确诊时的中位数年龄 (25.0岁) 和指示性血小板缺血 (9.0岁) 之间观察到显著的差异.
- 这表明日本人口中MYH9-RD的诊断延迟很大.
结论:
- 研究结果强烈表明,日本MYH9相关疾病的诊断延迟显著.
- 遗传性血小板缺血注册在识别和解决诊断挑战方面发挥着至关重要的作用.
- 持续的注册工作对于改善MYH9-RD的诊断和管理至关重要.
相关概念视频
Documentation of Nursing Diagnosis
1.8K
The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
1.8K
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
386
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
386
Myocarditis II: Clinical Features and Diagnostic Tests
497
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
497
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812


